BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29431240)

  • 21. Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.
    Wang H; Wang W; Wang X; Cai K; Wu H; Ju Q; Huang Z; Gao X
    Med Oncol; 2012 Dec; 29(5):3162-8. PubMed ID: 22528516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
    Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
    Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.
    Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H
    Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance.
    Nakashima H; Jiang SX; Sato Y; Hoshi K; Matsumoto T; Nagashio R; Kobayashi M; Matsuo Y; Shiomi K; Hayakawa K; Saegusa M; Satoh Y
    Pathol Int; 2015 Apr; 65(4):183-92. PubMed ID: 25684590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild-type epidermal growth-factor receptor cases.
    Mori S; Motoi N; Ninomiya H; Matsuura Y; Nakao M; Mun M; Okumura S; Nishio M; Morikawa T; Ishikawa Y
    Pathol Int; 2017 Jan; 67(1):37-44. PubMed ID: 27976463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
    Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
    Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced angiomotin p130 expression correlates with poor prognosis in lung adenocarcinoma.
    Jang SH; Cho HD; Lee JH; Lee HJ; Hong SA; Cho J; Kim HJ; Oh MH
    J Clin Pathol; 2017 Jul; 70(7):625-630. PubMed ID: 27980054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
    Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
    Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
    Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.
    Cui Y; Liu J; Yin HB; Liu YF; Liu JH
    Jpn J Clin Oncol; 2015 Sep; 45(9):854-9. PubMed ID: 26185140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.
    Hong JH; Roh KS; Suh SS; Lee S; Sung SW; Park JK; Byun JH; Kang JH
    Tumour Biol; 2015 Dec; 36(12):9327-37. PubMed ID: 26104764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Kurehara H; Sugito N; Tomoda K; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
    Dis Esophagus; 2006; 19(6):454-8. PubMed ID: 17069588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.
    Noh SJ; Baek HA; Park HS; Jang KY; Moon WS; Kang MJ; Lee DG; Kim MH; Lee JH; Chung MJ
    Pathol Res Pract; 2013 Jun; 209(6):365-70. PubMed ID: 23702379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.